A-SPINE Asia Co., Ltd. (TPEX:6758)
30.70
+0.20 (0.66%)
Oct 30, 2026, 10:49 AM CST
A-SPINE Asia Market Cap
A-SPINE Asia has a market cap or net worth of 402.78 million as of October 30, 2026. It is the 40,128th most valuable company in the world and the 2,304th biggest in Taiwan. Its market cap has decreased by 25.06% in one year.
Market Cap
402.78M
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#2,304 Taiwan
PE Ratio
n/a
ChartMarket Cap Chart
Since January 2, 2020, A-SPINE Asia's market cap has decreased from 1.20B to 402.78M, a decrease of -66.40%. That is a compound annual growth rate of -14.76%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 402.78M | -24.30% |
| Dec 31, 2025 | 532.11M | -1.00% |
| Dec 30, 2024 | 537.49M | 2.57% |
| Dec 29, 2023 | 524.02M | 2.37% |
| Dec 30, 2022 | 511.90M | -19.23% |
| Dec 10, 2021 | 633.81M | -18.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Diamond Biotechnology | 831.82M |
| Cowealth Medical Holding | 784.72M |
| Radiant Innovation | 769.04M |
| PlexBio | 694.45M |
| Carilex Medical | 652.77M |
| Health & Life | 463.65M |
| EPS Bio Technology | 345.10M |
| Amed Co., Ltd. | 330.00M |